Health and Economic Impact of COVID-19 Surveillance Testing in Seattle Homeless Shelters: A Cost-Effectiveness Analysis
Open Access
- 5 December 2024
- journal article
- Published by Elsevier in AJPM Focus
- Vol. 4 (2) , 100307
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- Bill and Melinda Gates Foundation
- California State University
- Merck
- Infectious Diseases Society of America
- Centers for Disease Control and Prevention (75D30120C09322 AM002)
- Gates Ventures LLC
This publication has 50 references indexed in Scilit:
- Cost-effectiveness Thresholds Used by Study Authors, 1990-2021JAMA, 2023
- Diagnostic accuracy of SARS-CoV-2 rapid antigen self-tests in asymptomatic individuals in the omicron period: a cross-sectional studyClinical Microbiology and Infection, 2022
- COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022JAMA Internal Medicine, 2022
- Disparities in COVID-19 Outcomes by Race, Ethnicity, and Socioeconomic StatusJAMA Network Open, 2021
- Specificity and positive predictive value of SARS-CoV-2 nucleic acid amplification testing in a low-prevalence settingClinical Microbiology and Infection, 2021
- Clinical Outcomes, Costs, and Cost-effectiveness of Strategies for Adults Experiencing Sheltered Homelessness During the COVID-19 PandemicJAMA Network Open, 2020
- Assessment of SARS-CoV-2 Screening Strategies to Permit the Safe Reopening of College Campuses in the United StatesJAMA Network Open, 2020
- Health Utility Weighting of the Modified Rankin ScaleJAMA Network Open, 2020
- Homelessness and the Response to Emerging Infectious Disease Outbreaks: Lessons from SARSJournal of Urban Health, 2008
- Vaccination versus treatment of influenza in working adults: A cost-effectiveness analysisThe American Journal of Medicine, 2005